RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Europo

Company

Owners

Owners

Co-owners of Euroonko for May 2024 are the chairman of the board of directors of the group of companies Khvich Akubardia (70%), general director Alexander Sviridov (20%) and Sberbank Investments (10%).

History

2024

Co-owner of Medskan holding bought Euroonko group

In September 2024, the co-owner of the Medskan holding, Yevgeny Tugolukov, acquired the Euroonko group of companies, which develops a federal network of expert oncology clinics under the same brand. The transaction was completed with the participation of Tetra JSC, the beneficial owner of which is Tugolukov. According to the results of corporate procedures and approvals of regulators, Tetra will become the full owner of Euroonko.

According to Vedomosti, Tetra has entered into agreements on the acquisition of 99.99% of the group's parent company, 812 Capital LLC, from the main owner of Euroonko, Khvichi Akubardia, and the general director of the network's management company, Alexander Sviridov.

Co-owner of Medskan bought Euroonko

Founder and Chairman of the Board of Directors of Euroonko Group Khvicha Akubardia expressed satisfaction with the transaction and noted that attracting a strategic investor is a recognition of the company's achievements. He stressed that for more than 13 years of work, the team of the Euroonko group of companies has built a model of an oncological clinic based on honesty, transparency and responsibility. According to him, this allows us to confidently look to the future and continue to develop high-quality medical services for patients.

Evgeny Tugolukov, in turn, noted that Euroonko is one of the leaders of private oncological medicine in Russia. He stressed the importance of the project to provide qualified medical care in the fight against cancer and expressed his readiness to continue to develop this business. Tugolukov also highly appreciated the merits of the Euroonko management team and expressed confidence that their competencies will help not only in the further development of the brand, but also in solving the problems facing other medical organizations.[1]

The court supported the position of the doctor "Euroonko" in a dispute with the herbalist

The judicial system Russia defended the doctor "Euroonko." Ekaterina Timofeeva The Arbitration Court upheld her position in a dispute with a certain herbalist promising cure cancer with the help of phytochay, creating an important judicial precedent for the entire medical community. Representatives medical that Zdrav.Expert of the Euroonko network shared this with the portal on June 3, 2024. More. here

2023: Sberbank bought 10% of Euroonko

Sber bought 9.99% of the Euroonko network of cancer clinics, which became known at the end of August 2023. According to the SPARK-Interfax system, Sberbank Investments acquired a stake from Euroonko CEO Khvichi Akubardia, who, as a result of the transaction, owned about 70% of the company (the rest from entrepreneur Alexander Sviridov).

A representative of Euroonco said To sheets"" that "the deal will allow the network to strengthen its position in the market and increase its competitiveness." Financial he declined to disclose details. Experts interviewed by the publication estimate the deal at 150-500 million, and the rubles cost of the entire Euroonko network is 2-4.5 billion rubles.

Sberbank bought 9.99% of the network of oncological clinics "Euroonko"

Euroonko specializes in the treatment of cancer and owns clinics in Moscow (Center for Innovative Medical Technologies), St. Petersburg, Krasnodar and Samara (by August 2023).

General Director of Infoline Analytics Mikhail Burmistrov, in a conversation with the publication, noted that interest in medical assets in the Russian Federation has increased amid growing demand for the services of domestic specialists. Earlier, many Russians believed that foreign doctors are more professional, but the possibilities of Russian medicine are expanding, the attitude towards specialists is changing, he explained.

According to Nikolai Bespalov, Development Director of RNC Pharma, due to sanctions, fewer citizens of the Russian Federation can visit other countries for treatment and patients are forced to contact domestic clinics.

The expert believes that Sberbank plans to resell the asset at the highest price than to engage in its strategic development. However, the head of DSM Group Sergey Shulyak believes that the bank will increase its stake in Euroonko due to its investment attractiveness.[2]

2021: Fake licence revocation claim at clinic

On November 17, 2021, it became known about the initiation of a criminal case in Moscow on the fact of license fraud in the Euroonko private clinic. Employees of a medical institution specializing in the treatment of cancer turned to law enforcement agencies after the appearance of a fake order to terminate the license.

According to TASS, citing its informant, an unknown person provided a fake statement about the termination of the licensed type of activity of Euroonko to the licensing and accreditation department of the city of Moscow.

Moscow authorities received a fake statement about the revocation of the license from the private clinic "Euroonko"

As explained to the news agency in the clinic, someone tried in this way to impede the work of providing medical care to the population, but the arbitration court stopped the order. The clinic continues to operate without restrictions by September 17, 2021. According to information received from regulatory authorities, the territorial body of Roszdravnadzor and the Moscow Department of Health (DZM) are not aware of the current situation and have no questions for the organization.

As follows from the materials of the Moscow Arbitration Court, the Euroonko license terminated on September 2, 2021, and on November 16, the court refused to invalidate this decision. At the same time, the court imposed interim measures and stopped the order of the DZM, in connection with which the clinic operates normally and without restrictions.

The leaders of Moscow clinics interviewed by TASS call the incident with the Euroonko clinic a "shocking story" and propose to tighten the requirements under similar circumstances.

A criminal case was opened under Part 3 of Art. 327 of the Criminal Code of the Russian Federation (use of a deliberately forged document). On the fact of the incident, the clinic appealed to the Moscow prosecutor's office, the Main Directorate of the Ministry of Internal Affairs of Russia in Moscow, the Main Directorate of the Investigative Committee of Russia in Moscow and the FSB of Russia in Moscow and the Moscow region.[3]

Notes